Ligand validation:4OPT

GRG: GERANYLGERANYL DIPHOSPHATE

GRG is a Ligand Of Interest in 4OPT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4OPT_GRG_A_502	21%	42%	0.175	0.785	0.7	1.51	-	8	0	0	100%	0.85
4OPD_GRG_B_502	99%	42%	0.047	0.987	0.67	1.57	-	6	2	0	100%	0.9
4OPI_GRG_A_502	17%	40%	0.216	0.796	0.72	1.61	-	8	1	0	100%	0.8
4OPU_GRG_A_503	13%	28%	0.266	0.837	0.7	2.17	-	10	3	0	86%	0.6897
4OPG_GRG_A_502	10%	42%	0.264	0.772	0.7	1.54	-	9	0	0	100%	0.95
2E8V_GRG_B_1502	86%	26%	0.088	0.957	1.84	1.18	8	5	0	0	100%	1
3PZ2_GRG_B_334	78%	16%	0.138	0.981	2.09	1.65	11	5	2	0	100%	1
1N4S_GRG_J_1505	76%	57%	0.12	0.958	0.77	0.89	-	1	1	0	100%	1
2Z4V_GRG_A_1401	73%	27%	0.141	0.968	1.83	1.14	8	3	1	0	100%	1
2Q80_GRG_A_500	67%	19%	0.153	0.962	1.97	1.48	11	6	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.